ZKSCAN7
gene geneOn this page
Also known as FLJ12738ZSCAN39
Summary
ZKSCAN7 (zinc finger with KRAB and SCAN domains 7, HGNC:12955) is a protein-coding gene on chromosome 3p21.31, encoding Zinc finger protein with KRAB and SCAN domains 7 (Q9P0L1). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 55888 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 106 total
- Transcription factor: yes — 14 downstream targets (CollecTRI)
- MANE Select transcript:
NM_001288590
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12955 |
| Approved symbol | ZKSCAN7 |
| Name | zinc finger with KRAB and SCAN domains 7 |
| Location | 3p21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ12738, ZSCAN39 |
| Ensembl gene | ENSG00000196345 |
| Ensembl biotype | protein_coding |
| Entrez | 55888 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 15 protein_coding, 1 nonsense_mediated_decay, 1 retained_intron
ENST00000273320, ENST00000341840, ENST00000418719, ENST00000419137, ENST00000426540, ENST00000431636, ENST00000447279, ENST00000496563, ENST00000896017, ENST00000896018, ENST00000896019, ENST00000932839, ENST00000946797, ENST00000946798, ENST00000946799, ENST00000946800, ENST00000946801
RefSeq mRNA: 5 — MANE Select: NM_001288590
NM_001288590, NM_001288591, NM_001288592, NM_018651, NM_025169
CCDS: CCDS2714, CCDS2715, CCDS74924
Canonical transcript exons
ENST00000426540 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000967144 | 44569922 | 44572158 |
| ENSE00001236042 | 44556930 | 44557470 |
| ENSE00001657475 | 44555193 | 44555481 |
| ENSE00003524420 | 44565487 | 44565655 |
| ENSE00003780619 | 44567912 | 44568003 |
| ENSE00003781396 | 44568307 | 44568433 |
Expression profiles
Bgee: expression breadth ubiquitous, 136 present calls, max score 81.61.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.3491 / max 79.6010, expressed in 1272 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 36332 | 5.3491 | 1272 |
Top tissues by expression
137 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.61 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.69 | gold quality |
| ganglionic eminence | UBERON:0004023 | 80.44 | gold quality |
| cortical plate | UBERON:0005343 | 79.77 | gold quality |
| ventricular zone | UBERON:0003053 | 75.61 | gold quality |
| islet of Langerhans | UBERON:0000006 | 75.13 | gold quality |
| endometrium | UBERON:0001295 | 74.24 | gold quality |
| right ovary | UBERON:0002118 | 73.89 | gold quality |
| ovary | UBERON:0000992 | 73.72 | gold quality |
| left ovary | UBERON:0002119 | 73.67 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 73.53 | gold quality |
| adrenal tissue | UBERON:0018303 | 73.22 | gold quality |
| pancreas | UBERON:0001264 | 72.33 | gold quality |
| pituitary gland | UBERON:0000007 | 72.22 | gold quality |
| fallopian tube | UBERON:0003889 | 72.19 | gold quality |
| right adrenal gland | UBERON:0001233 | 71.91 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 71.63 | gold quality |
| right uterine tube | UBERON:0001302 | 71.62 | gold quality |
| body of uterus | UBERON:0009853 | 71.57 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 71.56 | gold quality |
| cerebellum | UBERON:0002037 | 71.54 | gold quality |
| cerebellar cortex | UBERON:0002129 | 71.54 | gold quality |
| adrenal gland | UBERON:0002369 | 71.53 | gold quality |
| left adrenal gland | UBERON:0001234 | 71.50 | gold quality |
| stromal cell of endometrium | CL:0002255 | 71.48 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 71.40 | gold quality |
| lymph node | UBERON:0000029 | 71.38 | gold quality |
| apex of heart | UBERON:0002098 | 71.35 | gold quality |
| body of pancreas | UBERON:0001150 | 71.27 | gold quality |
| adenohypophysis | UBERON:0002196 | 70.76 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.58 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
14 targets.
| Target | Regulation |
|---|---|
| AP3B1 | |
| CBX1 | |
| CHEK2 | |
| EPCAM | |
| FGFR1 | |
| GDNF | |
| IGF2 | |
| INS | |
| KRT9 | |
| ME3 | |
| POU5F1 | Activation |
| PTCH1 | |
| TERT | |
| TRIM28 |
Upstream regulators (CollecTRI, top): PGR
miRNA regulators (miRDB)
79 targeting ZKSCAN7, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-3667-3P | 99.99 | 67.17 | 1636 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
| HSA-MIR-548C-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548D-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548H-5P | 99.94 | 71.24 | 3488 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zkscan7 | ENSMUSG00000063488 |
| rattus_norvegicus | Zkscan7 | ENSRNOG00000004104 |
Paralogs (51): WIZ (ENSG00000011451), ZNF416 (ENSG00000083817), MYNN (ENSG00000085274), PRDM4 (ENSG00000110851), PRDM2 (ENSG00000116731), ZBTB17 (ENSG00000116809), ZNF644 (ENSG00000122482), GZF1 (ENSG00000125812), ZNF426 (ENSG00000130818), ZNF287 (ENSG00000141040), ZNF697 (ENSG00000143067), ZNF687 (ENSG00000143373), ZNF214 (ENSG00000149050), ZNF547 (ENSG00000152433), ZNF776 (ENSG00000152443), ZNF230 (ENSG00000159882), ZNF222 (ENSG00000159885), ZNF233 (ENSG00000159915), ZNF333 (ENSG00000160961), ZNF319 (ENSG00000166188), ZNF592 (ENSG00000166716), ZNF646 (ENSG00000167395), ZNF507 (ENSG00000168813), ZNF768 (ENSG00000169957), ZNF417 (ENSG00000173480), ZNF408 (ENSG00000175213), ZBTB41 (ENSG00000177888), ZNF223 (ENSG00000178386), ZNF852 (ENSG00000178917), ZNF784 (ENSG00000179922), ZNF572 (ENSG00000180938), ZNF707 (ENSG00000181135), ZNF746 (ENSG00000181220), ZNF467 (ENSG00000181444), ZNF530 (ENSG00000183647), ZNF17 (ENSG00000186272), ZNF527 (ENSG00000189164), ZNF34 (ENSG00000196378), ZNF774 (ENSG00000196391), ZNF777 (ENSG00000196453)
Protein
Protein identifiers
Zinc finger protein with KRAB and SCAN domains 7 — Q9P0L1 (reviewed: Q9P0L1)
Alternative names: Zinc finger protein 167, Zinc finger protein 448, Zinc finger protein 64
All UniProt accessions (4): C9J6L6, Q9P0L1, E7EMM9, H7BZE7
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9P0L1-1 | 1 | yes |
| Q9P0L1-2 | 2 |
RefSeq proteins (5): NP_001275519, NP_001275520, NP_001275521, NP_061121, NP_079445 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR003309 | SCAN_dom | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR038269 | SCAN_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF02023
UniProt features (31 total): zinc finger region 13, sequence variant 7, domain 2, region of interest 2, compositionally biased region 2, splice variant 2, chain 1, cross-link 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9P0L1-F1 | 66.29 | 0.05 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 28
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 78 (showing top):
MODULE_255, MODULE_45, MODULE_317, MODULE_157, MODULE_113, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, MODULE_60, MODULE_38, MODULE_69, SCGGAAGY_ELK1_02, MODULE_13, POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP, MODULE_23, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MODULE_41
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872), sequence-specific double-stranded DNA binding (GO:1990837)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
568 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZKSCAN7 | TRIM28 | Q13263 | 944 |
| ZKSCAN7 | SETDB1 | Q15047 | 893 |
| ZKSCAN7 | CBX5 | P45973 | 592 |
| ZKSCAN7 | TRPS1 | Q9UHF7 | 555 |
| ZKSCAN7 | ZPR1 | O75312 | 521 |
| ZKSCAN7 | RUNX3 | Q13761 | 508 |
| ZKSCAN7 | EBF1 | Q9UH73 | 450 |
| ZKSCAN7 | MMP13 | P45452 | 423 |
| ZKSCAN7 | IHH | Q14623 | 403 |
| ZKSCAN7 | SPP1 | P10451 | 388 |
| ZKSCAN7 | YIPF2 | Q9BWQ6 | 370 |
| ZKSCAN7 | EHMT2 | Q96KQ7 | 370 |
| ZKSCAN7 | DOCK5 | Q9H7D0 | 370 |
| ZKSCAN7 | RUNX2 | Q13950 | 361 |
| ZKSCAN7 | DNMT3A | Q9Y6K1 | 349 |
IntAct
23 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SCAND1 | ZKSCAN7 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZKSCAN7 | ZKSCAN4 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZKSCAN7 | SCAND1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZKSCAN4 | ZKSCAN7 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZKSCAN7 | ZSCAN12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZKSCAN7 | ZNF446 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZKSCAN7 | ZSCAN21 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZSCAN21 | ZKSCAN7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZKSCAN7 | TIMM50 | psi-mi:“MI:0915”(physical association) | 0.400 |
| NFIC | ZKSCAN7 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZSCAN32 | ZKSCAN7 | psi-mi:“MI:0915”(physical association) | 0.370 |
| C9orf72 | CHD2 | psi-mi:“MI:0914”(association) | 0.350 |
| CBX2 | TRANK1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (27): ZKSCAN7 (Two-hybrid), ZKSCAN7 (Two-hybrid), ZKSCAN7 (Two-hybrid), ZKSCAN7 (Two-hybrid), ZKSCAN4 (Two-hybrid), ZKSCAN7 (Two-hybrid), ZKSCAN7 (Two-hybrid), ZKSCAN7 (Two-hybrid), TCEANC (Two-hybrid), ZKSCAN7 (Two-hybrid), ZKSCAN7 (Two-hybrid), ZSCAN12 (Two-hybrid), ZKSCAN7 (Reconstituted Complex), ZKSCAN7 (Two-hybrid), ZKSCAN7 (Two-hybrid)
ESM2 similar proteins: A1YEP8, A1YEV9, A1YFW2, A1YG26, A1YG48, A1YG60, A2T6E3, A2T6V8, A2T712, A2T736, A2T7D2, A2T7F4, A2T7L7, A2T812, A6QNZ0, O14709, O15535, O43296, O43309, P10073, P17023, P17097, P49910, Q07231, Q12901, Q15776, Q16670, Q1LZ87, Q3MJ62, Q53GI3, Q571J5, Q5JNZ3, Q5RAE6, Q5RBX0, Q5RCD9, Q5RJ54, Q7Z7L9, Q86W11, Q8IZ26, Q8NF99
Diamond homologs: A1YEP8, A1YEQ3, A1YEV9, A1YFW2, A1YFW6, A1YG26, A1YG48, A1YG60, A1YGJ4, A1YGK6, A2T6E3, A2T6V8, A2T6W2, A2T712, A2T736, A2T7D2, A2T7D7, A2T7F2, A2T7F4, A2T7L7, A2T812, A6QNZ0, A6QPT6, B2KFW1, O14709, O14771, O14978, O15535, O43309, O60304, O95125, P10073, P17022, P17028, P17029, P17040, P28698, P49910, P51815, P59923
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
106 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 91 |
| Likely benign | 10 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1523 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:44557468:G:GT | donor_gain | 1.0000 |
| 3:44568967:A:AG | acceptor_gain | 1.0000 |
| 3:44568967:ACTT:A | acceptor_gain | 1.0000 |
| 3:44586103:A:AG | acceptor_gain | 1.0000 |
| 3:44586104:G:GG | acceptor_gain | 1.0000 |
| 3:44557467:GGAG:G | donor_gain | 0.9900 |
| 3:44557468:GAGG:G | donor_loss | 0.9900 |
| 3:44557469:AGGT:A | donor_loss | 0.9900 |
| 3:44557470:GGTGA:G | donor_loss | 0.9900 |
| 3:44557471:G:GA | donor_loss | 0.9900 |
| 3:44557479:T:G | donor_gain | 0.9900 |
| 3:44565677:GCCT:G | donor_gain | 0.9900 |
| 3:44568968:C:G | acceptor_gain | 0.9900 |
| 3:44569915:T:TA | acceptor_gain | 0.9900 |
| 3:44569916:G:A | acceptor_gain | 0.9900 |
| 3:44586103:AGT:A | acceptor_gain | 0.9900 |
| 3:44586104:GT:G | acceptor_gain | 0.9900 |
| 3:44586104:GTG:G | acceptor_gain | 0.9900 |
| 3:44586212:GG:G | donor_gain | 0.9900 |
| 3:44586213:GG:G | donor_gain | 0.9900 |
| 3:44587236:G:GT | donor_gain | 0.9900 |
| 3:44587251:G:GG | donor_gain | 0.9900 |
| 3:44556928:A:AG | acceptor_gain | 0.9800 |
| 3:44556929:G:GG | acceptor_gain | 0.9800 |
| 3:44557468:GAG:G | donor_gain | 0.9800 |
| 3:44565553:G:GT | donor_gain | 0.9800 |
| 3:44567910:A:AG | acceptor_gain | 0.9800 |
| 3:44567911:G:GG | acceptor_gain | 0.9800 |
| 3:44567911:GCTCA:G | acceptor_gain | 0.9800 |
| 3:44568966:C:G | acceptor_gain | 0.9800 |
AlphaMissense
5003 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:44571040:T:C | F644L | 0.999 |
| 3:44571042:C:A | F644L | 0.999 |
| 3:44571042:C:G | F644L | 0.999 |
| 3:44571208:T:C | F700L | 0.999 |
| 3:44571210:T:A | F700L | 0.999 |
| 3:44571210:T:G | F700L | 0.999 |
| 3:44571059:T:C | L650P | 0.998 |
| 3:44571067:C:G | H653D | 0.998 |
| 3:44571124:T:C | F672L | 0.998 |
| 3:44571126:C:A | F672L | 0.998 |
| 3:44571126:C:G | F672L | 0.998 |
| 3:44571151:C:G | H681D | 0.998 |
| 3:44571227:T:C | L706P | 0.998 |
| 3:44571292:T:C | F728L | 0.998 |
| 3:44571294:T:A | F728L | 0.998 |
| 3:44571294:T:G | F728L | 0.998 |
| 3:44571071:A:C | Q654P | 0.997 |
| 3:44571235:C:G | H709D | 0.997 |
| 3:44571239:A:C | Q710P | 0.997 |
| 3:44570956:T:C | F616L | 0.996 |
| 3:44570958:T:A | F616L | 0.996 |
| 3:44570958:T:G | F616L | 0.996 |
| 3:44571069:C:A | H653Q | 0.996 |
| 3:44571069:C:G | H653Q | 0.996 |
| 3:44571143:T:C | L678P | 0.996 |
| 3:44571153:T:A | H681Q | 0.996 |
| 3:44571153:T:G | H681Q | 0.996 |
| 3:44570368:T:C | F420L | 0.995 |
| 3:44570370:C:A | F420L | 0.995 |
| 3:44570370:C:G | F420L | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1000291492 (3:44564793 T>G), RS1000373011 (3:44579639 T>C), RS1000420526 (3:44579435 G>A), RS1000530575 (3:44568814 A>G), RS1000595562 (3:44575001 T>C,G), RS1000645623 (3:44578228 T>C), RS1000700183 (3:44561810 G>A,C), RS1000938105 (3:44553409 G>T), RS1000938316 (3:44581745 C>G), RS1001130614 (3:44561584 A>G), RS1001217522 (3:44569113 G>A), RS1001256381 (3:44555557 G>C), RS1001285248 (3:44557507 C>T), RS1001550952 (3:44573574 A>G), RS1001694194 (3:44560495 G>C,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| GSK-J4 | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases methylation | 1 |
| testosterone undecanoate | affects cotreatment, increases expression | 1 |
| arsenite | increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| clothianidin | increases expression | 1 |
| eprenetapopt | affects expression, affects reaction | 1 |
| Sunitinib | decreases expression | 1 |
| Arbutin | decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Benztropine | decreases expression | 1 |
| Caffeine | increases phosphorylation | 1 |
| Calcitriol | increases expression | 1 |
| Cannabidiol | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Potassium Chloride | decreases expression, decreases response to substance | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Dronabinol | decreases expression, decreases response to substance | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Levonorgestrel | affects cotreatment, increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.